Fig. 7From: SU16f inhibits fibrotic scar formation and facilitates axon regeneration and locomotor function recovery after spinal cord injury by blocking the PDGFRβ pathwayIntrathecal injection of SU16f inhibits fibroblasts proliferation after SCI. A–H Immunofluorescence staining of BrdU (red), PDGFRβ (green) and nuclei (blue) in sagittal sections of the Control and SU16f groups at 7 dpi. I–P Immunofluorescence staining of Ki67 (red), PDGFRβ (green) and nuclei (blue) in sagittal sections of the Control and SU16f groups at 7 dpi. Q–R Quantification of the density of BrdU+PDGFRβ+ cells Q or Ki67+PDGFRβ+ cells R at 7 dpi. Scale bars: 20 μm. ****P < 0.0001 by Student’s t test, n = 5 animals per groupBack to article page